Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-operative propranolol versus placebo in breast cancer surgery
ACTRN12615000889550Phase 2Completed
- Sponsor
- Peter MacCallum Cancer Centre
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in breast cancer comparing Propranolol with Matched placebo (2 arms). Primary endpoint: Primary tumor gene expression. Started Jan 2016; status: completed.
02
Drugs
propranolol
03
Conditions
breast cancer
Beyond the preview
Go deeper on ACTRN12615000889550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000889550.